Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2004

Conditions

Insulin Resistance

Interventions

DRUG

Triflusal (DCI)

Trial Locations (1)

Unitat de Diabetologia, Endocrinologia y Nutrición Hosp Josep Trueta, Girona

All Listed Sponsors

lead

J. Uriach and Company

INDUSTRY

NCT00162799 - Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity | Biotech Hunter | Biotech Hunter